V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005106 | 290003731 | 1.64 | 0 | Palliative (P) | 2016-06-26 | 2016-06-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | N | 290022367 | CARBOPLATIN + PACLITAXEL |
| 290005107 | 290003732 | 1.6 | null | Palliative (P) | 2016-10-01 | 2016-10-07 | LANREOTIDE | N | N | 290022368 | CAPECITABINE + CISPLATIN |
| 290005108 | 290006611 | null | 179 | Palliative (P) | 2013-02-17 | 2013-02-19 | Capecitabine | 02 | N | 290022370 | CISPLATIN + ETOPOSIDE |
| 290005109 | 290003733 | 1.66 | 73 | null | 2015-07-19 | 2015-07-19 | Folfirinox | 02 | N | 290022372 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005110 | 290003734 | 1.74 | 90 | Neo-adjuvant (N) | 2015-07-12 | 2015-07-12 | Fluorouracil 96hr infusion+R(4g/m2) | 2 | N | 290022373 | Y-90 |
| 290005111 | 290003734 | 1.57 | 106 | Adjuvant (A) | 2013-12-05 | 2013-12-13 | CARBOPLATIN | N | N | 290022373 | TRIAL |
| 290005112 | 290003735 | 1.73 | null | null | 2013-06-14 | 2013-06-16 | Doxorubicin + Olaratumab | 02 | null | 290022377 | CAPECITABINE + RT |
| 290005113 | 290003736 | 1.8 | 71 | Neo-adjuvant (N) | 2013-06-14 | 2013-06-24 | Docetaxel 100mg/m2 (21 day) | 2 | N | 290022384 | PEMBROLIZUMAB |
| 290005114 | 290003737 | null | 81 | Palliative (P) | null | 2017-08-25 | Carboplatin + Etoposide iv&po | null | null | 290022385 | CARBOPLATIN |
| 290005115 | 290003738 | 1.7 | null | Palliative (P) | 2016-02-06 | 2016-02-08 | Capecitabine | N | N | 290022387 | CHOP R |
| 290005116 | 290003739 | null | 95.4 | Disease modification (D) | null | 2014-01-22 | Capecitabine | N | N | 290022389 | IBRUTINIB |
| 290005117 | 290003740 | 1.55 | 75.7 | Palliative (P) | 2013-10-13 | 2013-10-21 | Carboplatin + Pemetrexed | 2 | N | 290022390 | NIVOLUMAB |
| 290005118 | 290003741 | 1.72 | 64 | Palliative (P) | 2013-02-06 | 2013-08-01 | Doxorubicin chemoembolisation | 02 | N | 290022391 | GEMCITABINE |
| 290005119 | 290003742 | 1.71 | 98 | Palliative (P) | 2017-05-06 | 2017-05-26 | OCTREOTIDE | null | N | 290022393 | MITOMYCIN INTRAVESICULAR |
| 290005120 | 290006613 | 1.6 | null | Curative (C) | 2017-04-18 | 2017-05-16 | Ipilimumab | 2 | Y | 290022394 | PACLITAXEL |
| 290005121 | 290003743 | 1.81 | 57 | Palliative (P) | 2015-09-27 | 2015-10-15 | CETUXIMAB + CISPLATIN + FU | N | N | 290022397 | CARBOPLATIN + PEMETREXED |
| 290005122 | 290003744 | 1.65 | 61 | Palliative (P) | 2013-12-31 | 2014-01-11 | LANREOTIDE | 02 | N | 290022398 | CAPECITABINE |
| 290005123 | 290003744 | 0 | 62.4 | Neo-adjuvant (N) | 2017-08-03 | 2017-08-11 | LANREOTIDE | 01 | N | 290022398 | CAPECITABINE + IRINOTECAN |
| 290005124 | 290003745 | null | 74.3 | Curative (C) | 2014-06-06 | 2014-06-06 | CARBOPLATIN + PACLITAXEL | N | null | 290022400 | CAPECITABINE + RT |
| 290005125 | 290003745 | null | null | Palliative (P) | 2015-08-11 | 2015-09-04 | EOX | N | N | 290022400 | CAPECITABINE |
| 290005126 | 290003746 | 1.64 | 41.1 | Disease modification (D) | 2013-03-28 | 2013-04-07 | EOX | N | N | 290022405 | OCTREOTIDE |
| 290005127 | 290003746 | null | 54.45 | Adjuvant (A) | 2016-09-26 | 2016-09-26 | OCTREOTIDE | 2 | N | 290022405 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005128 | 290003747 | 1.65 | 46.2 | Adjuvant (A) | 2016-03-09 | 2016-03-15 | OCTREOTIDE | N | N | 290022407 | SUNITINIB |
| 290005129 | 290003747 | 1.59 | 0 | Palliative (P) | 2014-07-16 | 2014-07-29 | OCTREOTIDE | 02 | N | 290022407 | IRINOTECAN + MDG |
| 290005130 | 290007785 | 1.66 | 75.6 | Palliative (P) | null | 2013-02-01 | Capecitabine + Cisplatin | N | N | 290022409 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290005131 | 290003748 | 1.5 | 110.3 | Adjuvant (A) | null | 2014-01-02 | OCTREOTIDE | null | null | 290022410 | DOCETAXEL |
| 290005132 | 290003749 | null | 56 | Palliative (P) | 2016-10-06 | 2016-10-17 | Cisplatin +Fluorouracil (2 wk) | N | N | 290022411 | LANREOTIDE |
| 290005133 | 290003750 | 1.73 | 87.2 | Curative (C) | 2016-05-03 | 2016-05-05 | Carboplatin AUC 2 - 5 | 02 | N | 290022412 | CAPECITABINE |
| 290005134 | 290003751 | 1.6 | 66.65 | Palliative (P) | 2013-07-24 | 2013-08-19 | Trial Unspecified | N | N | 290022413 | CAPECITABINE + RT |
| 290005135 | 290003752 | 1.53 | 51.1 | Palliative (P) | 2017-06-07 | 2017-06-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 290022415 | CAPECITABINE + RT |
| 290005136 | 290003753 | 1.72 | 67.6 | Curative (C) | 2015-04-24 | 2015-05-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290022416 | CARBOPLATIN + PACLITAXEL |
| 290005137 | 290003754 | 1.6 | null | Neo-adjuvant (N) | 2014-12-04 | 2014-12-19 | LANREOTIDE | N | N | 290022417 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005138 | 290003755 | 1.64 | 53.2 | Adjuvant (A) | null | 2017-06-08 | Carboplatin AUC 2 - 5 | N | N | 290022420 | EOX |
| 290005139 | 290003756 | 1.77 | 60.8 | Curative (C) | 2014-09-08 | 2014-09-10 | OCTREOTIDE | null | null | 290022421 | CAPECITABINE |
| 290005140 | 290003757 | 1.8 | null | Palliative (P) | 2017-10-23 | 2017-11-19 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 290022424 | CAPECITABINE + IRINOTECAN |
| 290005141 | 290003758 | null | 46.4 | Adjuvant (A) | 2015-01-08 | 2015-01-08 | Docetaxel 75mg/m2 (21 day) | N | Y | 290022425 | CARBOPLATIN |
| 290005142 | 290003759 | 1.76 | 72 | Palliative (P) | 2016-09-19 | 2016-09-19 | Capecitabine 35days + RT | 02 | null | 290022427 | FLUOROURACIL |
| 290005143 | 290003760 | null | 62.7 | Disease modification (D) | 2017-06-06 | 2017-06-06 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 290022428 | DOXORUBICIN + IFOSFAMIDE |
| 290005144 | 290003760 | 0 | 75 | Curative (C) | 2017-03-11 | 2017-03-17 | Trial Unspecified | N | Y | 290022428 | TRIAL |
| 290005145 | 290003760 | null | 101 | Palliative (P) | 2016-01-28 | 2016-01-29 | CETUXIMAB | N | null | 290022428 | CHOP R |
| 290005146 | 290003761 | 1.73 | 53.6 | Palliative (P) | 2017-05-30 | 2017-05-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290022433 | MCX |
| 290005147 | 290003762 | 1.7 | 110 | Adjuvant (A) | 2016-07-28 | 2016-07-29 | Capecitabine 35days + RT | N | N | 290022436 | CISPLATIN + FLUOROURACIL |
| 290005148 | 290003763 | 1.72 | 110.2 | Palliative (P) | 2015-06-17 | 2015-06-17 | Fluorouracil + Folinic Acid Weekly | N | N | 290022437 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005149 | 290003764 | 1.58 | 73 | Curative (C) | null | 2016-02-20 | Capecitabine + Cisplatin | N | N | 290022438 | CHOP R |
| 290005150 | 290003764 | 1.72 | 121.6 | Neo-adjuvant (N) | 2013-06-13 | 2014-06-28 | Capecitabine (21days) + Carboplatin | 02 | N | 290022438 | CARBOPLATIN + ETOPOSIDE |
| 290005151 | 290003764 | 1.75 | 73.8 | Curative (C) | null | 2017-02-04 | Capecitabine | N | N | 290022438 | LANREOTIDE |
| 290005152 | 290003764 | 1.54 | 65 | Adjuvant (A) | null | 2015-11-01 | Capecitabine | N | N | 290022438 | CAPECITABINE |
| 290005153 | 290003764 | 1.76 | 115.1 | Neo-adjuvant (N) | 2016-03-16 | 2016-06-07 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290022438 | CAPECITABINE + RT |
| 290005154 | 290003765 | 1.46 | 87 | Curative (C) | 2014-10-30 | 2014-10-31 | Sunitinib | 02 | null | 290022454 | CAPECITABINE |
| 290005155 | 290003765 | 1.57 | 97 | Curative (C) | 2016-06-10 | 2016-07-01 | CAPECITABINE + RT | 02 | N | 290022454 | ECX |